Stay updated with breaking news from Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 1,190,000 shares, a drop of 16.2% from the August 15th total of 1,420,000 shares. Based on an average trading volume of 647,900 shares, the days-to-cover ratio […] ....
StockNews.com cut shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning. Several other brokerages have also recently issued reports on CDTX. Needham & Company LLC reissued a buy rating and issued a $3.00 price objective on shares of […] ....
Needham & Company LLC restated their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report report published on Friday morning, Benzinga reports. The firm currently has a $3.00 target price on the biotechnology company’s stock. CDTX has been the subject of a number of other reports. HC Wainwright reaffirmed […] ....
HC Wainwright reissued their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a report released on Thursday morning, Benzinga reports. HC Wainwright currently has a $6.00 target price on the biotechnology company’s stock. Other research analysts have also recently issued reports about the stock. TheStreet cut shares of Cidara Therapeutics from […] ....
HC Wainwright reaffirmed their buy rating on shares of Cidara Therapeutics (NASDAQ:CDTX – Free Report) in a research report report published on Thursday, Benzinga reports. HC Wainwright currently has a $6.00 price objective on the biotechnology company’s stock. A number of other research firms have also commented on CDTX. TheStreet lowered shares of Cidara Therapeutics […] ....